ApprovalTrail

Approval · Notice of Compliance 32204 · 2023

KALYDECO: Notice of Compliance 32204

Issued November 28, 2023

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
32204
Date
November 28, 2023
Company
Vertex Pharmaceuticals (Canada) IncorporatedToronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Priority
Reason
Expansion of indication. Addition of new strength Updates to the Product Monograph. Updates to labels. Updates to package insert

Products in this notice

BrandDINStatus today
KALYDECONot yet assigned—
KALYDECO02543451Marketed

Medicinal ingredients